November / December 1997

Vol 4, No 6 CME Pretest

In this issue, the topic of radioguided surgery is addressed. First, answer the pretest questions below. After reading the articles, proceed with answering the CME posttest questions.

This Journal provides 4 hours of Category I Continuing Medical Education

Complimentary CME Credits

Physicians can earn up to 4 credit hours of Category I for the Physician's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions on the posttest at the end of this issue. Complete instructions are given on the posttest pages. Every successfully answered 10 questions will earn 1 credit hour. CME is presented by an unrestricted educational grant from Bristol-Myers Oncology Division.

Educational Objectives

After reading this issue, clinicians will be expected to:

• describe the roles for radioguided surgery for melanoma, carcinoma of the breast and bowel, bone metastasis, and parathyroid tumors; and
  
• appreciate a systematic approach to minimizing inappropriate or incorrect chemotherapy administration.
  

This program was planned in accordance with ACCME Essentials.
Release Date: November 1, 1997 Expiration Date: November 1 , 1998

Pretest

1. What is the appropriate incidence of "skip metastases" in the lymphatic basins of patients with melanoma who have had "sentinel" nodes removed that contain no metastases?

a. close to 0%

b. 10%

c. 20%

d. 30%

2. The centers that are experienced with using the "sentinel node" technique for staging patients with breast cancer report what percentage of success in identifying sentinel lymph nodes?

a. over 90%

b. 85% to 90%

c. 75% to 80%

d. 60% to 70%

3. The median survival of patients with colorectal cancer after second-look surgery when the patient was assessed to have operable tumor by both traditional and radioimmunoguided surgery technology is:

a. 1 year

b. 2 years

c. 3 years

d. more than 5 years